WEBINAR: Evidence Based Optometric Clinical Guidance on Diabetes and GLP-1 Receptor Agonists

Lecture by Dr. Andrew Morgenstern

Description:

This course will review the most up to date information on GLP-1 Receptor Agonists from the AOA Clinical Report and how these medications affect Optometric clinical care

Objectives:

1. Review the history and epidemiology of GLP-1 RA's
2. Discuss the systemic effects, benefits and risks of GLP-1's
3. Discuss the ocular effects, benefits and risks of GLP-1's
4. Discuss the rare risk of NAION and who is at risk
5. Review when to refer and treat patients on GLP-1's

This course will not be submitted to COPE; it will be accepted by the PA State Board of Optometry for license renewal. If you hold a license in another state, please check with your State Board prior to registering.